Human Papillomavirus Testing in Cervical Cancer Screening

Philip E. Castle; Miriam Cremer

doi:10.1016/j.ogc.2013.03.002

Human Papillomavirus Testing in Cervical Cancer Screening

Philip E. Castle, Miriam Cremer

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women. In high-resource settings, HPV testing can be used to make cervical cancer prevention programs more efficient by focusing clinical attention on women who have HPV. In lower-resource settings, where Pap testing has not been sustained or widespread, new, lower-cost HPV tests may make cervical cancer screening feasible.

Original language	English (US)
Pages (from-to)	377-390
Number of pages	14
Journal	Obstetrics and Gynecology Clinics of North America
Volume	40
Issue number	2
DOIs	https://doi.org/10.1016/j.ogc.2013.03.002
State	Published - Jun 2013
Externally published	Yes

Keywords

Cervical cancer
Cervical intraepithelial neoplasia
Human papillomavirus (HPV)
Low-resource settings
Pap testing
Screening
Vaccination
Visual inspection after acetic acid (VIA)

ASJC Scopus subject areas

Obstetrics and Gynecology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ogc.2013.03.002

Cite this

@article{a521ce277f664f328943681b7c3cea01,

title = "Human Papillomavirus Testing in Cervical Cancer Screening",

abstract = "Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women. In high-resource settings, HPV testing can be used to make cervical cancer prevention programs more efficient by focusing clinical attention on women who have HPV. In lower-resource settings, where Pap testing has not been sustained or widespread, new, lower-cost HPV tests may make cervical cancer screening feasible.",

keywords = "Cervical cancer, Cervical intraepithelial neoplasia, Human papillomavirus (HPV), Low-resource settings, Pap testing, Screening, Vaccination, Visual inspection after acetic acid (VIA)",

author = "Castle, {Philip E.} and Miriam Cremer",

year = "2013",

month = jun,

doi = "10.1016/j.ogc.2013.03.002",

language = "English (US)",

volume = "40",

pages = "377--390",

journal = "Obstetrics and Gynecology Clinics of North America",

issn = "0889-8545",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Human Papillomavirus Testing in Cervical Cancer Screening

AU - Castle, Philip E.

AU - Cremer, Miriam

PY - 2013/6

Y1 - 2013/6

N2 - Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women. In high-resource settings, HPV testing can be used to make cervical cancer prevention programs more efficient by focusing clinical attention on women who have HPV. In lower-resource settings, where Pap testing has not been sustained or widespread, new, lower-cost HPV tests may make cervical cancer screening feasible.

AB - Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women. In high-resource settings, HPV testing can be used to make cervical cancer prevention programs more efficient by focusing clinical attention on women who have HPV. In lower-resource settings, where Pap testing has not been sustained or widespread, new, lower-cost HPV tests may make cervical cancer screening feasible.

KW - Cervical cancer

KW - Cervical intraepithelial neoplasia

KW - Human papillomavirus (HPV)

KW - Low-resource settings

KW - Pap testing

KW - Screening

KW - Vaccination

KW - Visual inspection after acetic acid (VIA)

UR - http://www.scopus.com/inward/record.url?scp=84878625615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878625615&partnerID=8YFLogxK

U2 - 10.1016/j.ogc.2013.03.002

DO - 10.1016/j.ogc.2013.03.002

M3 - Review article

C2 - 23732037

AN - SCOPUS:84878625615

VL - 40

SP - 377

EP - 390

JO - Obstetrics and Gynecology Clinics of North America

JF - Obstetrics and Gynecology Clinics of North America

SN - 0889-8545

IS - 2

ER -

Human Papillomavirus Testing in Cervical Cancer Screening

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this